Aakash Gajjar, MD
Colon & Rectal Surgery · Houston, TXNPI 1730115106
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 80.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $3,343 and has fallen 88.2% since, to $395 in 2025.
Across 41 payments — averaging $134.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Teva Pharmaceuticals USA, Inc.$233
- Abbott$193
- E.r. Squibb & Sons, L.L.C.$125
- Medtronic$117
- Johnson & Johnson$110
- plus $282 from 11 others
What the payments were for
- Consulting fees$952%
- Speaking & faculty fees$2,95054%
- Travel & lodging$97818%
- Food & beverage$1,45326%
- Education$120%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $4,437 |
| Teva Pharmaceuticals USA, Inc. | 1 | $233 |
| Abbott | 2 | $193 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Medtronic | 4 | $117 |
| Johnson & Johnson(2 entities) | 3 | $110 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $71 |
| Stryker | 1 | $41 |
| Acell, Inc. | 1 | $27 |
| Davol Inc. | 1 | $22 |
| THD America, Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| TELA Bio, Inc. | 1 | $19 |
| Activ Surgical, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,178
- UZEDY$233
- ZEPOSIA$125
- CARDIOMEMS$100
How this compares
$5,497 in reported general payments places this provider in the 55th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 13 | $1,352 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 71 | $913 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 25 | $301 |
| Neomycin Sulfate | 19 | $114 |
| Metronidazole | 21 | $73 |
| Tramadol Hcl | 20 | $59 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Houston
- Diego Marines CopadoHouston$462K
- Erik AskenasyHouston$142K
- Eric HaasHouston$140K
- Theodoros VoloyiannisHouston$100K
- Scott McKnightHouston$73K
- Tsuyoshi KonishiHouston$68K
- Jean-Paul LefaveHouston$47K
- George ChangHouston$31K
- Michael SnyderHouston$24K
- Marianne CusickHouston$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.